Alabama law protects physicians who prescribe meds for off-label use

Alabama passed a law that prohibits the state’s board of medical examiners and medical licensure commission from taking adverse action against physicians who prescribe or recommend off-label medical treatments, the Alabama Reflector reported May 20.

Advertisement

“This bill just allowed a doctor to do what they’re already doing without any fear of reprisal from the State Medical Board,” Sen. Arthur Orr told the news outlet.

The law indicates it’s the physician’s role to look at the risks and benefits of medication and inform the patient of what is and isn’t known, David Williams, MD, told the Reflector.

The issue of off-label prescription became prominent at the beginning of the COVID-19 pandemic when some physicians in some states faced adverse action for prescribing off-label treatment.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.